Print

Progenics Pharmaceuticals, Inc. (PGNX) to Present at the Biotechnology Industry Organization (BIO) International Convention  
6/18/2012 9:46:47 AM

TARRYTOWN, N.Y., June 15, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) chief executive officer Mark R. Baker will present at the 2012 BIO International Convention's Business Forum, a unique venue where biotechnology companies, academic research institutions and investors intersect to review strategic opportunities. Mr. Baker will give a corporate overview on Monday, June 18 at 1:45 PM ET in the Boston Convention & Exhibition Center, Boston, MA.
//-->